Clinical Trial Update: Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the safety, efficacy, and dose evaluation of ProSavin for bilateral idiopathic Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ProSavin

Snippet

Sponsor: Oxford BioMedica | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED